Chan Sub Park

456 total citations
37 papers, 285 citations indexed

About

Chan Sub Park is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chan Sub Park has authored 37 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 11 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chan Sub Park's work include Breast Cancer Treatment Studies (13 papers), Advanced Breast Cancer Therapies (6 papers) and Breast Implant and Reconstruction (5 papers). Chan Sub Park is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Advanced Breast Cancer Therapies (6 papers) and Breast Implant and Reconstruction (5 papers). Chan Sub Park collaborates with scholars based in South Korea, China and United States. Chan Sub Park's co-authors include Ho Yong Park, Jeeyeon Lee, Jin Hyang Jung, Wan Wook Kim, Hyun‐Ah Kim, In‐Chul Park, Min-Ki Seong, Eun Ja Lee, Woo Chul Noh and Jae‐Sung Kim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Radiology.

In The Last Decade

Chan Sub Park

30 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chan Sub Park South Korea 11 78 75 59 52 48 37 285
Miklós Szűcs Hungary 9 53 0.7× 86 1.1× 46 0.8× 90 1.7× 17 0.4× 39 263
Iryna Samarska Netherlands 11 44 0.6× 56 0.7× 117 2.0× 77 1.5× 12 0.3× 41 308
Handan Kaya Türkiye 8 27 0.3× 45 0.6× 61 1.0× 54 1.0× 30 0.6× 25 196
Alberto Dalla Volta Italy 10 94 1.2× 107 1.4× 102 1.7× 47 0.9× 28 0.6× 37 321
Jean H. Lee United States 11 115 1.5× 58 0.8× 93 1.6× 29 0.6× 217 4.5× 21 418
Hanh Thi Tuyet Ngo Vietnam 9 34 0.4× 80 1.1× 52 0.9× 64 1.2× 44 0.9× 14 338
Nimmi S. Kapoor United States 8 145 1.9× 112 1.5× 86 1.5× 34 0.7× 15 0.3× 27 303
Manabu Arai Japan 11 68 0.9× 125 1.7× 190 3.2× 15 0.3× 84 1.8× 14 358
Angela C. Chen United States 10 24 0.3× 28 0.4× 49 0.8× 90 1.7× 44 0.9× 21 247

Countries citing papers authored by Chan Sub Park

Since Specialization
Citations

This map shows the geographic impact of Chan Sub Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chan Sub Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chan Sub Park more than expected).

Fields of papers citing papers by Chan Sub Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chan Sub Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chan Sub Park. The network helps show where Chan Sub Park may publish in the future.

Co-authorship network of co-authors of Chan Sub Park

This figure shows the co-authorship network connecting the top 25 collaborators of Chan Sub Park. A scholar is included among the top collaborators of Chan Sub Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chan Sub Park. Chan Sub Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Se‐Lim, Hyunggee Kim, Ki Soo Park, et al.. (2025). Bemcentinib enhances sensitivity to estrogen receptor inhibitors in breast cancer cells. The International Journal of Biochemistry & Cell Biology. 180. 106750–106750.
2.
Han, Wonshik, Eunhye Kang, Hong‐Kyu Kim, et al.. (2025). Personalized neoadjuvant strategy using 70-gene assay to increase breast-conserving surgery in ER+/HER2– breast cancer. npj Breast Cancer. 11(1). 57–57.
3.
Kim, Se‐Lim, Chan Sub Park, Hyun‐Ah Kim, et al.. (2024). Proapoptotic role of CDK1 in overcoming paclitaxel resistance in ovarian cancer cells in response to combined treatment with paclitaxel and duloxetine. Cancer Cell International. 24(1). 409–409. 1 indexed citations
4.
Park, In‐Chul, Min-Ki Seong, Woo Chul Noh, et al.. (2023). Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy. Annals of Surgical Treatment and Research. 105(1). 1–1.
5.
Choi, Jung Eun, Zisun Kim, Chan Sub Park, et al.. (2023). Breast Cancer Statistics in Korea, 2019. Journal of Breast Cancer. 26(3). 207–207. 31 indexed citations
6.
Kim, Yu Jin, Sung‐Eun Hong, Chan Sub Park, et al.. (2023). Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors. Anticancer Research. 43(5). 1973–1980. 11 indexed citations
7.
8.
Lee, Jeeyeon, Ho Yong Park, Wan Wook Kim, et al.. (2021). Value of accurate diagnosis for metastatic supraclavicular lymph nodes in breast cancer: assessment with neck US, CT, and 18F-FDG PET/CT. Diagnostic and Interventional Radiology. 27(3). 323–328. 2 indexed citations
9.
Park, Ji Young, Ji Yun Jeong, Ji Young Park, et al.. (2021). Peritumoral edema in breast cancer at preoperative MRI: an interpretative study with histopathological review toward understanding tumor microenvironment. Scientific Reports. 11(1). 12992–12992. 35 indexed citations
10.
Hong, Sung‐Eun, Hyeon‐Ok Jin, Chan Sub Park, et al.. (2021). miR-3188 Enhances Sensitivity of Breast Cancer Cells to Ionizing Radiation by Down-regulating Rictor. Anticancer Research. 41(12). 6169–6176. 4 indexed citations
11.
Park, Chan Sub, Min-Ki Seong, Hyesil Seol, et al.. (2020). Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status. Journal of Breast Cancer. 23(1). 10–10. 3 indexed citations
12.
Park, Ho Yong, Wan Wook Kim, Chan Sub Park, et al.. (2020). Clinical efficacy of intraoperative ultrasound for margin assessment in breast‐conserving surgery. The Breast Journal. 26(11). 2308–2311.
13.
Kim, Wan Wook, et al.. (2020). Real Scarless Transoral Robotic Thyroidectomy Using Three Ports Without Axillary Incision. Journal of Laparoendoscopic & Advanced Surgical Techniques. 30(11). 1165–1171. 5 indexed citations
14.
Lee, Jeeyeon, Jung Dug Yang, Jeong Woo Lee, et al.. (2020). Acellular dermal matrix combined with oxidized regenerated cellulose for partial breast reconstruction. Medicine. 99(31). e21217–e21217. 9 indexed citations
15.
Kim, Changho, Jong Kun Kim, Jae Young Choe, et al.. (2020). Appendectomy in patient with suspected COVID-19 with negative COVID-19 results: A case report. World Journal of Clinical Cases. 8(10). 1944–1949. 4 indexed citations
16.
Park, Chan Sub, Hyesil Seol, In‐Chul Park, et al.. (2020). Predicting Radiation Resistance in Breast Cancer with Expression Status of Phosphorylated S6K1. Scientific Reports. 10(1). 641–641. 28 indexed citations
17.
Lee, Jeeyeon, Jin Hyang Jung, Wan Wook Kim, Chan Sub Park, & Ho Yong Park. (2020). Patterns of Delaying Surgery for Breast Cancer During the COVID-19 Outbreak in Daegu, South Korea. Frontiers in Surgery. 7. 576196–576196. 6 indexed citations
18.
19.
Lee, Jeeyeon, Jin Hyang Jung, Wan Wook Kim, et al.. (2019). Absence of estrogen receptor is associated with worse oncologic outcome in patients who were received neoadjuvant chemotherapy for breast cancer. Asian Journal of Surgery. 43(3). 467–475. 6 indexed citations
20.
Lee, Eun Ja, So Lyung Jung, Bum‐Soo Kim, et al.. (2005). MR Imaging of Orbital Inflammatory Pseudotumors with Extraorbital Extension. Korean Journal of Radiology. 6(2). 82–82. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026